Evaluation and Treatment of Patients With Dermatologic Diseases
Systemic Diseases With Cutaneous Manifesations
|Study Design:||Time Perspective: Prospective|
|Official Title:||Evaluation and Treatment of Subjects With Dermatologic Diseases|
- Provide clinical material [ Time Frame: Ongoing ] [ Designated as safety issue: No ]
- Natural history of selected dermatologic diseases [ Time Frame: Ongoing ] [ Designated as safety issue: No ]
|Study Start Date:||June 1996|
This is a training, natural history of disease, and screening protocol for the evaluation, treatment and follow-up of patients with dermatologic diseases and systemic diseases with cutaneous manifestations. This protocol was developed to allow subject enrollment for teaching purposes and to allow for second opinions regarding relatively complicated patients. The latter function promotes a critical link between the NCI, CCR Dermatology Branch and the local and national extramural medical communities.
- To provide clinical material to fulfill the educational mission of the
- To learn about the natural history of selected dermatologic diseases.
- To screen patients for inclusion in other protocols.
- To assist in the diagnosis and/or management of patients with rare skin diseases and congenital or genetically linked skin conditions.
All subjects regardless of age, gender, or racial/ethnic group with dermatologic disease or systemic disease with cutaneous manifestations.
Patients enrolled in this protocol will be evaluated and treated according to generally available, standard procedures and therapeutic modalities. Samples of blood and skin will be studied by routine and specialized investigative methods to establish these patients diagnosis, response to treatment, and/or disease progression.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00001506
|Contact: Sharon Osgood, R.N.||(301) email@example.com|
|Contact: Mark C Udey, M.D.||(301) firstname.lastname@example.org|
|United States, Maryland|
|National Institutes of Health Clinical Center, 9000 Rockville Pike||Recruiting|
|Bethesda, Maryland, United States, 20892|
|Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office (888) NCI-1937|
|Principal Investigator:||Mark C Udey, M.D.||National Cancer Institute (NCI)|